Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
6.02M
-
Shares change
-
-129K
-
Total reported value, excl. options
-
$2.58M
-
Value change
-
-$60.4K
-
Number of buys
-
5
-
Number of sells
-
-7
-
Price
-
$0.43
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q4 2023
27 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q4 2023.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.02M shares
of 386M outstanding shares and own 1.56% of the company stock.
Largest 10 shareholders include HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (1.63M shares), STONEHILL CAPITAL MANAGEMENT LLC (1.51M shares), RENAISSANCE TECHNOLOGIES LLC (1.35M shares), ACADIAN ASSET MANAGEMENT LLC (685K shares), Whitefort Capital Management, LP (410K shares), Cambridge Investment Research Advisors, Inc. (111K shares), BECKER CAPITAL MANAGEMENT INC (90K shares), CITADEL ADVISORS LLC (32.5K shares), WEALTHSOURCE PARTNERS, LLC (30.2K shares), and Aristides Capital LLC (28.1K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.